Drug · DIN 02473232
FASENRA
SINGLE-DOSE PREFILLED SYRINGE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 28, 2018; first marketed March 28, 2018.
- Drug Identification Number (DIN)
- 02473232
- Company (DIN owner)
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Schedule
- Schedule d; Prescription
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Benralizumab R03DX10
- Class
- Human
- Record last updated
- August 28, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BENRALIZUMAB | 30 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 22, 2018: NOC 20519New Drug Submission (NDS)